Bernhard Reis

2.1k total citations · 1 hit paper
25 papers, 1.2k citations indexed

About

Bernhard Reis is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Bernhard Reis has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Bernhard Reis's work include Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (6 papers). Bernhard Reis is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (6 papers). Bernhard Reis collaborates with scholars based in Switzerland, Germany and United States. Bernhard Reis's co-authors include Bernd Bodenmiller, Dana Pe’er, Laurie Ailles, Karīna Siliņa, Carola H. Ries, Christian Beisel, Michael Stadler, Holger Moch, Vito Riccardo Tomaso Zanotelli and Daniel Schulz and has published in prestigious journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Bernhard Reis

23 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Immune Atlas of Clear Cell Renal Cell Carcinoma

2017 694 citations Stéphane Chevrier, Jacob Levine et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernhard Reis Switzerland	13	512	511	507	296	284	25	1.2k
Falguni Parikh India	13	474 0.9×	747 1.5×	425 0.8×	155 0.5×	327 1.2×	50	1.3k
Jena D. French United States	16	294 0.6×	668 1.3×	650 1.3×	292 1.0×	120 0.4×	27	1.7k
Carlos E. de Andrea Spain	24	381 0.7×	418 0.8×	434 0.9×	338 1.1×	209 0.7×	50	1.3k
Andrew D. Simmons United States	19	583 1.1×	652 1.3×	289 0.6×	325 1.1×	169 0.6×	60	1.2k
Stephan Herbertz Germany	7	584 1.1×	426 0.8×	205 0.4×	245 0.8×	195 0.7×	10	1.1k
Sumita Trivedi United States	17	417 0.8×	843 1.6×	583 1.1×	289 1.0×	170 0.6×	33	1.5k
Jörn Dietrich Germany	20	706 1.4×	465 0.9×	308 0.6×	187 0.6×	242 0.9×	33	1.1k
Toru Hiruma Japan	21	770 1.5×	309 0.6×	331 0.7×	455 1.5×	100 0.4×	46	1.4k
Baiyong Li China	21	524 1.0×	649 1.3×	691 1.4×	170 0.6×	144 0.5×	66	1.5k
María Villalba Spain	20	407 0.8×	366 0.7×	341 0.7×	143 0.5×	232 0.8×	35	959

Countries citing papers authored by Bernhard Reis

Since Specialization

Citations

This map shows the geographic impact of Bernhard Reis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Reis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Reis more than expected).

Fields of papers citing papers by Bernhard Reis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Reis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Reis. The network helps show where Bernhard Reis may publish in the future.

Co-authorship network of co-authors of Bernhard Reis

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Reis. A scholar is included among the top collaborators of Bernhard Reis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Reis. Bernhard Reis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bentley, Darren, et al.. (2024). A randomized, double‐blind, placebo‐controlled, multiple dose, parallel study to investigate the effects of a cathepsin S inhibitor in celiac disease. Clinical and Translational Science. 18(1). e13901–e13901.

Reis, Bernhard, et al.. (2024). Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers. Frontiers in Immunology. 15. 1285049–1285049. 7 indexed citations

Cannarile, Michael A., Vaios Karanikas, Bernhard Reis, et al.. (2023). Facts and Hopes on Biomarkers for Successful Early Clinical Immunotherapy Trials: Innovative Patient Enrichment Strategies. Clinical Cancer Research. 30(8). 1448–1456. 1 indexed citations

Melero, Ignacio, Iben Spanggaard, Dae Woo Lee, et al.. (2023). 617 A Phase I study of a tumor-targeted, fibroblast activation protein (FAP)-CD40 agonist (RO7300490) in patients with advanced solid tumors. SHILAP Revista de lepidopterología. A703–A703. 3 indexed citations

Barlési, Fabrice, Martijn P. Lolkema, Kristoffer Staal Rohrberg, et al.. (2020). 291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors. Regular and Young Investigator Award Abstracts. A178.1–A178. 9 indexed citations

Pradier, Melanie F., Bernhard Reis, Lori Jukofsky, et al.. (2019). Case-control Indian buffet process identifies biomarkers of response to Codrituzumab. BMC Cancer. 19(1). 278–278. 3 indexed citations

Daoudlarian, Douglas, Michel Theron, Fabrice A. Kolb, et al.. (2019). Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome. Arthritis Research & Therapy. 21(1). 175–175. 25 indexed citations

Pao, William, Chia-Huey Ooi, Fabian Birzele, et al.. (2018). Tissue-Specific Immunoregulation: A Call for Better Understanding of the “Immunostat” in the Context of Cancer. Cancer Discovery. 8(4). 395–402. 63 indexed citations

Theron, Michel, Fabrice A. Kolb, Marianne Manchester, et al.. (2018). FRI0295 Inhibition of cathepsin s leads to suppression of antigen specific t cells from patients with primary sjÖgren syndrome. Annals of the Rheumatic Diseases. 77. 684–684. 2 indexed citations

10.

Chen, Gong, Ya‐Chi Chen, Bernhard Reis, et al.. (2018). Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab. Oncotarget. 9(12). 10436–10444. 13 indexed citations

11.

Theron, Michel, Ana Patrícia Silva, Bernhard Reis, et al.. (2017). Cathepsin S inhibition suppresses autoimmune-triggered inflammatory responses in macrophages. Biochemical Pharmacology. 146. 151–164. 33 indexed citations

12.

Theron, Michel, Darren Bentley, Marianne Manchester, et al.. (2017). Pharmacodynamic Monitoring of RO5459072, a Small Molecule Inhibitor of Cathepsin S. Frontiers in Immunology. 8. 806–806. 36 indexed citations

13.

Chevrier, Stéphane, Jacob Levine, Vito Riccardo Tomaso Zanotelli, et al.. (2017). An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 169(4). 736–749.e18. 694 indexed citations breakdown →

14.

Rapozo, Davy, Bernhard Reis, Cláudio Canetti, et al.. (2016). Recurrent acute thermal lesion induces esophageal hyperproliferative premalignant lesions in mice esophagus. Experimental and Molecular Pathology. 100(2). 325–331. 14 indexed citations

15.

Schellens, Jan H.M., Josep Tabernero, Ulrik Lassen, et al.. (2015). CEA-targeted engineered IL2: Clinical confirmation of tumor targeting and evidence of intra-tumoral immune activation.. Journal of Clinical Oncology. 33(15_suppl). 3016–3016. 12 indexed citations

16.

Allantaz, Florence, Donavan T. Cheng, Tobias Bergauer, et al.. (2012). Expression Profiling of Human Immune Cell Subsets Identifies miRNA-mRNA Regulatory Relationships Correlated with Cell Type Specific Expression. PLoS ONE. 7(1). e29979–e29979. 169 indexed citations

17.

Beer‐Hammer, Sandra, Eva Zebedin, Judith Alferink, et al.. (2010). The catalytic PI3K isoforms p110γ and p110δ contribute to B cell development and maintenance, transformation, and proliferation. Journal of Leukocyte Biology. 87(6). 1083–1095. 56 indexed citations

18.

Reis, Bernhard, Klaus Pfeffer, & Sandra Beer‐Hammer. (2009). The orphan adapter protein SLY1 as a novel anti-apoptotic protein required for thymocyte development. BMC Immunology. 10(1). 38–38. 12 indexed citations

19.

Reis, Bernhard, et al.. (2008). Reduced notch activity is associated with an impaired marginal zone B cell development and function in Sly1 mutant mice. Molecular Immunology. 46(5). 969–977. 14 indexed citations

20.

Beer, Sandra, et al.. (2005). Impaired Immune Responses and Prolonged Allograft Survival in Sly1 Mutant Mice. Molecular and Cellular Biology. 25(21). 9646–9660. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact